Doxycycline Hyclate Tablets — Class II drug recall D-1024-2018
Terminated recall by West-Ward Columbus Inc, reported 2018-08-08, distributed nationwide. Failed Dissolution Specifications:
| Recall number | D-1024-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | West-Ward Columbus Inc, Columbus, OH, United States |
| Recall initiated | 2018-07-24 |
| Classified | 2018-08-02 |
| Reported by FDA | 2018-08-08 |
| Terminated | 2020-04-29 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 00143-2112, 00143-2112-05, 00143-2112-20, 00143-2112-50 |
| Lot numbers | 01/19, 71545B |
Product
Doxycycline Hyclate Tablets, USP, 100 mg*. 50-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-50.
Reason for recall
Failed Dissolution Specifications:
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1024-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.